Methotrexate for treatment of graft versus host disease after allogeneic hematopoietic stem cell transplantation

National Medical Journal of China

Volumn 85, Issue 16, 2005, Pages 1097-1101

  Huang, Xiao Jun ^a   Jiang, Qian ^a   Chen, Huan ^a   Xu, Lan Ping ^a   Liu, Dai Hong ^a   Chen, Yu Hong ^a   Han, Wei ^a   Zhang, Yao Chen ^a   Liu, Kai Yan ^a   Lu, Dao Pei ^a  

^a PEKING UNIVERSITY   (China)

Author keywords

Graft versus host disease; Hematopoietic stem cell transplantation; Methotrexate

Indexed keywords

IMMUNOSUPPRESSIVE AGENT; METHOTREXATE;

ACUTE GRAFT VERSUS HOST DISEASE; ADOLESCENT; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; LYMPHOCYTE TRANSFUSION; MALE; SHORT COURSE THERAPY; SIDE EFFECT; TREATMENT FAILURE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CHILD; FEMALE; GRAFT VS HOST DISEASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOID; LEUKEMIA, MYELOID, CHRONIC; MALE; METHOTREXATE; MIDDLE AGED; STEM CELL TRANSPLANTATION;

EID: 20944434722     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Huang XJ, Han W, Xu LP, et al. A novel approach to HLA-mismatched transplantation. J Peking Univer (Health Sci), 2004, 36:229-233.
2. Thomas ED, Storb R, Clift RA, et al. Bone marrow transplantation. New Engl J Med, 1975, 292:832-843,895-902.
3. Ratanatharathorn V, Ayash L, Lazarus HM, et al. Chronic graft-versus-host disease: clinical manifestation and therapy. Bone Marrow Transplantation, 2001, 28:121-129.
4. Sullivan KM, Witherspoon RP, Storb R, et al. Prednisone and azathioprine compared with prednisone and placebo for treatment of chronic graft versus host disease: prognostic influence of prolonged thrombocytopenia after allogeneic marrow transplantation. Blood, 1988, 72:546-554.
5. Storb R, Deeg HJ, Fisher L, et al. Cyclosporine vs methotrexate for graft-versus-host disease prevention in patients given marrow graft for leukemia: long-term follow-up of three controlled trial. Blood, 1988, 71:293-298.